EUVIMEDEUVIMED entdecken
MetaanalyseSystematische ÜbersichtOpen Access · CC BY 4.0

Systemic immune-inflammation index as a prognostic marker in pancreatic ductal adenocarcinoma: a metaanalysis

Bence Pachinger-Molnár, Otília Menyhárt

Cancer Treatment and Research Communications · 2026

DOI: 10.1016/j.ctarc.2026.101326 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Cancer Treatment and Research Communications, 2026. Verfasst von Bence Pachinger-Molnár und 1 weiteren Autor:innen. Beteiligte Einrichtung: Semmelweis University, Department of Bioinformatics, H-1094, Budapest, Hungary. Electronic address: pmbm13@gmail.com. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Inflammation. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hungarian Scientific Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal malignancy with limited durable treatment options despite evolving multimodal and systemic strategies. Systemic inflammation has emerged as a clinically relevant determinant of outcomes in several cancers. The systemic immune-inflammation index (SII; platelet count x neutrophil count / lymphocyte count) integrates key circulating immune cell populations and may serve as an accessible prognostic biomarker in PDAC. METHODS: A systematic search of PubMed was performed for studies published up to 11 April 2025. Eligible full-text English studies reported hazard ratios (HRs) with 95% confidence intervals (CIs) for overall survival (OS) according to SII (typically high versus low SII, defined by a study-specific cutoff). Pooled HRs were calculated using an inverse-variance random-effects model. Heterogeneity was assessed using Cochran's Q and the I2 statistic. Small-study effects were evaluated by funnel plot inspection and Egger's regression test. RESULTS: Seventeen studies (18 datasets) comprising 4218 patients were included. Elevated SII was associated with worse OS (pooled HR 1.58, 95% CI 1.19 - 2.08; p < 0.01). Between-study heterogeneity was substantial (I2 = 89.9%). Funnel plot inspection did not suggest major asymmetry, and Egger's test did not provide statistical evidence of small-study effects (p = 0.072). CONCLUSIONS: Elevated SII is associated with poorer overall survival and represents a practical prognostic biomarker derived from routine laboratory testing. Considerable heterogeneity across studies-likely driven by differences in case mix, treatment context, and SII cutoff definitions-underscores the need for standardized thresholds and prospective, harmonized validation studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsInflammationHumansPrognosisBiomarkers, TumorNeutrophilsPlatelet CountLymphocyte Count

Stichwörter der Autor:innen

MetaanalysisOverall survivalPancreatic ductal adenocarcinomaPrognostic biomarkerSystemic immune-inflammation index

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Semmelweis University, Department of Bioinformatics, H-1094, Budapest, Hungary. Electronic address: pmbm13@gmail.com.
  • Semmelweis University, Department of Bioinformatics, H-1094, Budapest, Hungary; Cancer Biomarker Research Group, Institute of Molecular Life Sciences, Hungarian Research Network, Magyar Tudósok körútja 2, 1117, Budapest…

Förderung

  • Hungarian Scientific Research Fund

Zitieren

APA

Pachinger-Molnár, B., & Menyhárt, O. (2026). Systemic immune-inflammation index as a prognostic marker in pancreatic ductal adenocarcinoma: a metaanalysis. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2026.101326

Vancouver

Pachinger-Molnár B, Menyhárt O. Systemic immune-inflammation index as a prognostic marker in pancreatic ductal adenocarcinoma: a metaanalysis. Cancer Treatment and Research Communications. 2026. doi:10.1016/j.ctarc.2026.101326

BibTeX
@article{PachingerMolnr2026,
  author = {Pachinger-Molnár, Bence and Menyhárt, Otília},
  title = {Systemic immune-inflammation index as a prognostic marker in pancreatic ductal adenocarcinoma: a metaanalysis},
  journal = {Cancer Treatment and Research Communications},
  year = {2026},
  doi = {10.1016/j.ctarc.2026.101326}
}
Kostenlos starten →